Mother’s wrongful death lawsuit claims daughter from Scranton died from kratom use
A wrongful death lawsuit claims a Scranton woman died from a product containing kratom, a botanical native to Southeast Asia. With a scientific name of Mitragyna speciosa, kratom is a tropical tree in ...
Hazleton Standard Speaker6d
Mother’s wrongful death lawsuit claims daughter died from kratom use
A wrongful death lawsuit claims a Scranton woman died from a product containing kratom, a botanical native to Southeast Asia.
FDA approves Susvimo for diabetic macular edema
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...
HealthDay on MSN4d
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Smithsonian Magazine5d
FDA Approves Transplant Trials for Gene-Edited Pig Kidneys
The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...
Genentech : FDA Approves Susvimo For Diabetic Macular Edema Treatment
Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has approved Susvimo ...
Daily Journal6d
FDA Approves Susvimo for Diabetic Macular Edema
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema. Susvimo is the first and only ...
Seeking Alpha5d
Supernus: New Approval Holds Promise Of Increased Growth
Supernus Pharmaceuticals' ONAPGO for Parkinson’s Disease received FDA approval, providing a basis for optimism despite past regulatory challenges with SPN-830. The company is methodically ...
KTEN6d
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.
Daily Journal5d
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
THURSDAY, Feb. 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion ...
Hosted on MSN5d
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Cure Today1d
Breaking Down the FDA Labeling Update of Xeloda and 5-FU in Cancer Care
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...